Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2012 Jun 1;86(6):982–987. doi: 10.4269/ajtmh.2012.11-0419

Brain Magnetic Resonance Imaging Findings in Young Patients with Hepatosplenic Schistosomiasis Mansoni without Overt Symptoms

Adonis Manzella 1,*, Paulo Borba-Filho 1, Carlos T Brandt 1, Keyla Oliveira 1
PMCID: PMC3366544  PMID: 22665605

Abstract

The purpose of this study was to describe the brain magnetic resonance imaging (MRI) findings in young patients with hepatosplenic schistosomiasis mansoni without overt neurologic manifestations. This study included 34 young persons (age range = 9–25 years) with hepatosplenic schistosomiasis mansoni who had been previously treated. Patients were scanned on a 1.5-T system that included multiplanar pre-contrast and post-contrast sequences, and reports were completed by two radiologists after a consensus review. Twenty (58.8%) patients had MRI signal changes that were believed to be related to schistosomiasis mansoni. Twelve of the 20 patients had small focal hyperintensities on T2WI in the cerebral white matter, and eight patients had symmetric hyperintense basal ganglia on T1WI. There was a high frequency of brain MRI signal abnormalities in this series. Although not specific, these findings may be related to schistosomiasis.

Introduction

According to the World Health Organization, schistosomiasis affects more than 200 million persons in several countries in Africa, Asia, or America and remains a major public health problem.1,2 Schistosomiasis is an infection caused by digenetic trematode platyhelminths of the genus Schistosoma, and the three main species are S. mansoni, S. japonicum, and S. hematobium.3,4 The species S. mansoni infects approximately 12 million persons in Brazil, which characterizes this country as an endemic area.5 The most severe presentation of the disease is hepatosplenic schistosomiasis mansoni (HSM), which is characterized by splenomegaly, periportal fibrosis, portal hypertension, and upper digestive bleeding caused by rupture of esophageal varices.6 Ectopic schistosomiasis infection of the central nervous system (CNS) is unusual. Cerebral lesions are caused primarily by S. japonicum, whereas spinal cord lesions are usually caused by S. mansoni and S. haematobium.2 In patients in Brazil with fatal HSM, autopsies showed that 26% have brain involvement.7

Reports of magnetic resonance imaging (MRI) findings associated with CNS schistosomiasis have described expansive lesions with variable enhancement patterns, such as diffuse, spotty, nodular, or central linear and nodular.813 There have been some isolated reports of brain MRI findings in patients with schistosomiasis mansoni. However, these cases are usually found in symptomatic patients with the granulomatous form of the disease. No systematic brain MRI studies of patients with HSM have been published. The purpose of this investigation was to prospectively describe brain MRI findings in young patients with HSM without overt neurologic symptoms who had been previously treated.

Materials and Methods

Thirty-four young outpatients (age range = 9–25 years, mean ± SD age = 16.5 ± 3.4 years) with the proven severe form of HSM were included in this investigation. Twenty-four (70.6%) patients were male and 10 (29.4%) were female. All patients came from a region hyperendemic for schistosomiasis mansoni, Zona da Mata, a sugar cane plantation area in the State of Pernambuco in northeastern Brazil, which had a prevalence greater than 25%. Diagnosis was established by a positive Kato-Katz test result or a quantitative oogram performed by using three rectal biopsy specimens and abdominal ultrasound examination, which demonstrated Symmers fibrosis grades II and III. These patients had been previously treated with oxamniquine (20 mg/kg, single dose) and had undergone splenectomy, ligature of the left gastric vein, and auto-implantation of spleen tissue into a pouch of the major omentum. Patient ages at the time of surgery ranged from 8 to 16 years. Post-operative rather than pre-operative patients were chosen because many of these young persons with severe HSM at Hospital das Clínicas da Universidade Federal de Pernambuco had already undergone surgery.

Patients with other hepatic diseases (cirrhosis, congenital hepatic fibrosis, hepatitis), history of alcoholism, prior neurologic diseases, hypertension or other vascular diseases, and those using any drugs with liver and/or brain toxicity were excluded. Persons with contraindications to MRI examinations were also excluded.

Neurologic assessment.

All patients underwent neurological evaluation by an experienced neurologist. They underwent a comprehensive neurologic workup that included a detailed history and neurologic examination and a battery of neuropsychologic tests including Kohs and Wechsler tests. The Kohs test is a block design test used to analyze the cognitive capacity of children and adolescents. It is used mainly to test persons with language or hearing handicaps. The Wechsler Intelligence Scales are a series of standardized tests used to evaluate cognitive abilities and intellectual abilities in children and adults.

Magnetic resonance imaging of the brain.

The MRI scans were conducted by using a 1.5-T Philips (Amsterdam, The Netherlands) Gyroscan System using standard axial, sagittal, and coronal spin-echo, T1WI (repetition time = 500–562 milliseconds, echo time = 14 milliseconds) with a matrix size of 143–203 × 512 pixels, and a slice thickness of 5 or 6 mm, with an inter-slice gap of 0.5–0.6 mm. Axial and coronal turbo spin-echo T2WI (echo time = 90–100 milliseconds with a repetition time of 2,022–4,811 milliseconds) and axial fluid attenuated inversion recovery (FLAIR) images (repetition time = 6,000 milliseconds, echo time = 100 milliseconds, inversion time = 2,000 milliseconds) were also obtained. After paramagnetic contrast administration (standard dose of 0.1 mmol/kg of body weight), axial and coronal SE T1WI were performed. Diffusion images were obtained for only three patients and were all normal.

The MRI scan was interpreted by two radiologists who were experts in neuroradiology. Both examiners viewed the images together and reached a consensus before writing reports. Results were categorized as normal and brain MRI findings that could possibly be related to schistosomiasis. Brain MRI-unrelated abnormalities were not included in the analysis.

Ethical considerations.

The recommendations of the World Health Organization and the Declaration of Helsinki (1975) in terms of protecting the rights and well-being of persons studied were followed. At the end of the study, all patients were informed about the results of the examinations and received appropriate recommendations, treatment, and referrals. The ethical committee of Hospital das Clínicas, Universidade Federal de Pernambuco approved this study. The patients and/or their parents signed a consent form after a full explanation of the study was provided.

Data analysis.

Results are expressed by their frequencies in percentages.

Results

At neurologic examination, all patients were oriented in time and space. There were no signs of acute encephalitis or encephalomyelitis. No signs of slow-expanding intracranial lesions (headache, seizures, papilledema, visual abnormalities, speech disturbances, sensory impairment, hemiparesis, nystagmus, ataxia) were seen.

None of the patients had clinical symptoms of hepatic encephalopathy. However, intelligence and cognitive evaluation showed abnormal Kohs test results for 27 (79.4%) patients and abnormalities in Wechsler test results for 7 (20.6%) patients. Liver function test results for each patient were normal at the time of the MRI examination.

MRI of the brain.

Nine (26.5%) of the patients in this series had normal brain MRI examination results. Of the 34 MRI procedures conducted, 25 (73.5%) showed abnormalities on T1 and/or T2WI. However, only 20 (58.8%) demonstrated lesions that could be related to schistosomiasis, although no enhancement with contrast material (CM) injection was seen.

Eight (40%) of 20 patients with brain MRI signal changes possibly related to schistosomiasis showed on T1WI bilateral and symmetrical hyperintensities that were restricted to certain brain areas, particularly globus pallidus, cerebral peduncles, or both. A variable degree of hypersignal was noted in those patients. In addition, hyperintensity at the floor of the fourth ventricle was observed in two patients. There was no radiologic counterpart on T2WI for these abnormalities. Typical examples of these changes are shown in Figure 1. The pituitary gland appeared homogeneously hyperintense on T1WI in one patient (Figure 1D).

Figure 1.

Figure 1.

Magnetic resonance images of patient 18, a 15-year-old girl with hepatosplenic schistosomiasis without neurologic symptoms. Axial spin-echo T1WI demonstrate symmetrical and bilateral hyperintensity at the level of the globus pallidus (A), cerebral peduncles (B) and at the floor of the fourth ventricle (C) (arrows). Sagittal spin-echo T1WI (D) shows a white pituitary gland (small arrow).

The MRI findings of the brain in 60% (12 of 20) of the patients with significant signal changes showed small focal T2 and FLAIR hyperintensities involving the cerebral white matter (Figure 2). These focal areas of T2 hyperintensities were predominantly seen in the frontal lobes (91.7%) and 54.5% were bilaterally distributed. The number of hyperintensities in each person varied from four to ten and their sizes were less than 1 cm. Three of these patients had concomitant bilateral and symmetrical hyperintensities on T1WI in the globus pallidus and cerebral peduncles.

Figure 2.

Figure 2.

Magnetic resonance images of patient 14, a 15-year-old boy with schistosomiasis mansoni. Axial fluid attenuated inversion recovery (A) and TSE-T2WI (B) show small focal hyperintensities in the white matter of the left frontal lobe (small arrows).

Two patients showed involvement of the corpus callosum. One of them had a small oval lesion with low signal on T1 and FLAIR and high signal by T2WI.

The distribution of the frequencies of the brain MRI signal abnormalities is shown in Table 1. The distribution of the frequencies of the brain MRI findings according to their categorization is shown in Table 2.

Table 1.

Distribution of frequencies of brain magnetic resonance imaging signal abnormalities in 20 young patients with hepatosplenic schistosomiasis mansoni without overt symptoms*

Image description No. %
T1-weighted bilateral and symmetrical hyperintensities 8 40.0
 Globus pallidus 7/8 87.5
 Cerebral peduncle 7/8 87.5
 Floor of the fourth ventricle 2/8 25.0
 Pituitary gland 1/8 12.5
Focal T2 and FLAIR hyperintensities 12 60.0
 Bilateral white matter 6/12 50.0
 Unilateral white matter 6/12 50.0
 Corpus callosum 1/12 8.3
 Oval lesion with high signal on T2 and low signal on T1 and FLAIR involving the corpus callosum 1 5.0
*

FLAIR = fluid attenuated inversion recovery.

Some patients showed concomitant magnetic resonance imaging findings.

Table 2.

Distribution of frequencies of the brain magnetic resonance imaging according to their categorization in 34 young patients with hepatosplenic schistosomiasis mansoni without overt symptoms*

Result No. %
Normal 9 26.5
MRI findings that could possibly be related to schistosomiasis 20 58.8
 Focal T2 and FLAIR hyperintensities involving the cerebral white matter (unilateral or bilateral) 12 60
 T1-weighted bilateral and symmetrical hyperintensities particularly restricted to globus pallidus and cerebral peduncles or both. 8 40
 Oval lesion with high signal on T2 and low signal on T1 and FLAIR involving the corpus callosum 1 5.0
*

MRI = magnetic resonance imaging; FLAIR = fluid attenuated inversion recovery.

Some patients showed concomitant MRI findings.

Discussion

Schistosomiasis is a widespread disease in the developing world and is one of the most important helminthic infections in terms of public health. Patterns of schistosomiasis infection are shaped by two factors: host exposure and host immunity. The conditions responsible for evolution to severe forms of the disease are not completely clear although parasite burden seems to be a major determinant.14

Involvement of CNS may be observed with any of the clinical forms of schistosomal infection. In almost all symptomatic cases of neuroschistosomiasis mansoni (NS), involvement of the CNS starts in the early stages of infection, during disease evolution to its chronic forms, or concomitantly with the chronic intestinal and hepatointestinal forms.3 In situ ova deposition after anomalous migration of adult worms appears to be the main, if not the only, mechanism by which S. mansoni may reach the CNS in patients with the intestinal and hepatointestinal forms of the parasitosis. The mass effect produced by the heavy concentration of ova and granulomas in circumscribed areas of the spinal cord and brain explains the severe neurologic symptoms observed in these patients.

Although more frequent, CNS involvement associated with the hepatosplenic and cardiopulmonary forms is almost always asymptomatic. The random distribution of ova in the CNS of patients with these forms suggests that ova are carried there mainly as emboli by the arterial system or through retrograde venous flow.3,4,8,15,16 Because of the discrete inflammatory reaction elicited by the sparsely distributed ova, neurologic symptoms attributable to ova deposition are not present in most neuroschistosomiasis mansoni patients with the hepatosplenic and cardiopulmonary forms.7,1517

To the best of our knowledge, this investigation reports the largest number of HSM patients studied with brain MRI signal abnormalities. Every patient included in this study had been previously treated and none had any neurologic complaints. None of them had brain MRI abnormalities consistent with the tumoral form of cerebral schistosomiasis. The images did not reveal abnormal enhancement after the administration of the paramagnetic contrast material.

The few reported cases of cerebral schistosomiasis showed expansive lesions with surrounding edema and nodular, ring, or heterogeneous enhancement, and in some cases an arborized appearance. All patients had neurologic manifestations.4,9,13,16,18,19

There are no published reports addressing brain MRI findings in persons with HSM with or without neurologic manifestations. However, many investigations in which brain MRI findings were obtained were conducted with patients with cirrhosis, including persons with hepatic encephalopathy,2028 and with children with congenital portal-systemic encephalopathy (PSE).27,28 The MRI results showed typical neuroradiologic findings of PSE characterized by bilateral and symmetrical T1-weighted hyperintensities, particularly in the basal ganglia of these patients. The exact mechanism of hepatic encephalopathy and abnormal MRI findings is not clear, and the pathogenesis remains unknown.28 It was initially proposed that these findings were caused by increased levels of serum ammonia.

Presently, the most widely accepted hypothesis for the hyperintensity of the basal ganglia seen on T1-weighted MRI in patients with PSE is deposition of manganese.2931 Manganese is a paramagnetic transitional metal that is able to promote T1 shortening in MRI examinations, and several studies have supported the manganese hypothesis.3234 The T1-weighted high signal intensity of the globus pallidus was observed in 40% (8 of 20) of the patients with significant brain MRI signal abnormalities in this group and concomitant involvement of the cerebral peduncles was seen in six patients. A variable degree of hyperintensity was detected with higher signal in some cases. There has been a case report of schistosomal PSE in a young woman in Brazil in whom MRI showed high signal on T1WI in the globus pallidus, subthalamic regions, and cerebral peduncles.32

Although the patients described in this series had similar MRI findings, none had any neurologic manifestations and none had abnormal liver function test results. Liver function test results may be almost completely within normal limits or only slightly abnormal despite liver involvement in patients with HSM.35 Thus, based on review of medical literature, it is possible that the same pathogenesis may be implicated in the finding of T1-weighted hyperintensity in the basal ganglia in eight patients in this study, although serum manganese levels were not measured. To support this hypothesis, it would be necessary to include serum manganese levels and/or neuropathologic studies. Proton magnetic resonance spectroscopy could also be useful.

The most frequent MRI findings in the present series were small focal T2 and FLAIR hyperintensities involving the cerebral white matter, predominantly in the frontal lobes. This finding was observed in 60% (12 of 20) of the abnormal MRI results believed to be related to schistosomiasis. These lesions are not specific and can be related to ischemic changes, gliosis, or demyelinating diseases.

There have been few MRI studies describing the occurrence of T2 hyperintensities in the cerebral white matter in patients with chronic hepatic encephalopathy. One study that correlated MRI results with histologic findings in two autopsy-proven cases of chronic hepatic encephalopathy demonstrated that cortical hyperintensities on T2-weighted images represented pseudolaminar spongy degeneration in the deep layers of the cerebral cortices, and hyperintensities in the cerebral white matter represented tissue rarefaction associated with loss of myelin and axons.36 It has also been reported that T2 hyperintensities in the cerebral white matter found in patients with liver cirrhosis can normalize after successful liver transplantation, suggesting that they may reflect mild edema.24,36,37 The hyperintense lesions seen on T2 and FLAIR in these patients could also reflect mild edema or loss of myelin and axons, although the patients were much younger than patients reported in the literature and none of them had clinical signs of hepatic encephalopathy. However, we cannot exclude the possibility that these brain MRI changes may also have been caused by scattered isolated Schistosoma ova in nervous tissue and by the discrete inflammatory reaction surrounding the ova. Although this series included only post-operative patients, it seems less likely that these brain findings could be caused by surgery. All studies were conducted at least one year after surgery and most of them many years after surgery. This surgical approach has been shown to decrease portal hypertension and to maintain the hepatic functional reserve.

An association of schistosomiasis and endomyocardial fibrosis or cardiomyopathy has been suggested.38,39 It seems less likely that the lesions found in 12 patients in this study could be caused by microembolism related to endomyocardial fibrosis in the context of S. mansoni infestation.

There is a reported case of cerebral schistosomiasis caused by S. hematobium in a man who showed by computer tomography and MRI a cortical oval lesion in the left occipital lobe, which appeared to be a cyst.18 An oval lesion similar to this description was detected in the corpus callosum in one patient and could also be associated with schistosomiasis mansoni.

Cognitive functions were affected in some of these patients, suggesting a possible association with brain MRI changes. However, no conclusions can be drawn from this study because of lack of an age-matched control group and the fact that educational level and nutritional status of the patients could have influenced the results.

There was a high frequency of brain MRI signal abnormalities in young patients with HSM without overt neurologic manifestations. These findings are not commonly seen in healthy young persons, suggesting that there may be a relationship between these abnormalities and schistosomiasis, and that this relationship may be found even in patients without liver dysfunction.

It was not possible to determine if the lesions were the result of hemodynamic disorders, metabolic changes, deposition of eggs, or deposition of immune complexes. Further studies including an age-matched control population are necessary for proper interpretation of the MRI results.

Footnotes

Authors' addresses: Adonis Manzella, Paulo Borba-Filho, and Carlos T. Brandt, Hospital das Clínicas da Universidade Federal de Pernambuco, Avenida Professor Moraes Rego s/n, Cidade Universitária, Recife, Pernambuco, Brazil 50670-420, E-mails: adonismanzella@yahoo.com.br, pauloborbahc@yahoo.com.br, and carlosbrandt@bol.com.br. Keyla F. Oliveira, Hospital Universitário Oswaldo Cruz, Universidade de Pernambuco, Rua Arnobio Marques 310, Santo Amaro, Recife, Pernambuco, Brazil 50100-130, E-mails: keyla.fontes@uol.com.br.

References

  • 1.Coura JR, Amaral RS. Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas. Mem Inst Oswaldo Cruz. 2004;99:13–19. doi: 10.1590/s0074-02762004000900003. [DOI] [PubMed] [Google Scholar]
  • 2.Magalhães-Santos IF, Lemaire DC, Andrade-Filho AS, Queiroz AC, Carvalho OM, Carmo TM, Siqueira IC, Andrade DM, Rego MF, Guedes AP, Reis MG. Antibodies to Schistosoma mansoni in human cerebrospinal fluid. Am J Trop Med Hyg. 2003;68:294–298. [PubMed] [Google Scholar]
  • 3.Pittella JE. Neuroschistosomiasis. Brain Pathol. 1997;7:649–662. doi: 10.1111/j.1750-3639.1997.tb01080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Betting LE, Pirani C, Queiroz LS, Damasceno BP, Cendes F. Seizures and cerebral schistosomiasis. Arch Neurol. 2005;62:1008–1010. doi: 10.1001/archneur.62.6.1008. [DOI] [PubMed] [Google Scholar]
  • 5.Carvalho OA, Carvalho CM, Bacelar AL, Andrade-Filho AS, Costa G, Fontes JB, Assis T. Clinical and cerebrospinal fluid (CSF) profile and CSF criteria for the diagnosis of spinal cord schistosomiasis. Arq Neuropsiquiatr. 2003;61:353–358. doi: 10.1590/s0004-282x2003000300006. [DOI] [PubMed] [Google Scholar]
  • 6.Cleva R, Saad WA, Herman P. Portal hyperflow in patients with hepatosplenic mansonic schistosomiasis. Rev Hosp Clin Fac Med Sao Paulo. 2004;59:10–14. doi: 10.1590/s0041-87812004000100003. [DOI] [PubMed] [Google Scholar]
  • 7.Pittella JE, Lana-Peixoto MA. Brain involvement in hepatosplenic schistosomiasis mansoni. Brain. 1981;104:621–632. doi: 10.1093/brain/104.3.621. [DOI] [PubMed] [Google Scholar]
  • 8.Ferrari TCA. Involvement of central nervous system in the schistosomiasis. Mem Inst Oswaldo Cruz. 2004;99:59–62. doi: 10.1590/s0074-02762004000900010. [DOI] [PubMed] [Google Scholar]
  • 9.Pittella JE, Gusmao SN, Carvalho GT, da Silveira RL, Campos GF. Tumoral form of cerebral schistosomiasis mansoni: a report of cases and a review of the literature. Clin Neurol Neurosurg. 1996;98:15–20. doi: 10.1016/0303-8467(95)00075-5. [DOI] [PubMed] [Google Scholar]
  • 10.Shail E, Siqueira EB, Haider A, Halim M. Neuroschistosomiasis myelopathy: case report. Br J Neurosurg. 1994;8:239–242. doi: 10.3109/02688699409027976. [DOI] [PubMed] [Google Scholar]
  • 11.Ueki K, Parisi JE, Onofrio BM. Schistosoma mansoni infection involving the spinal cord: case report. J Neurosurg. 1995;82:1065–1067. doi: 10.3171/jns.1995.82.6.1065. [DOI] [PubMed] [Google Scholar]
  • 12.Bennett G, Provenzale JM. Schistosomal myelitis: findings at MR imaging. Eur J Radiol. 1998;27:268–270. doi: 10.1016/s0720-048x(98)00006-0. [DOI] [PubMed] [Google Scholar]
  • 13.Sanelli PC, Lev MH, Gonzalez RG, Schaefer PW. Unique linear and nodular MR enhancement pattern in schistosomiasis of the central nervous system. AJR. 2001;177:1471–1474. doi: 10.2214/ajr.177.6.1771471. [DOI] [PubMed] [Google Scholar]
  • 14.Coutinho EM, Abath FG, Barbosa CS, Domingues AL, Melo MC, Montenegro SM, Lucena MA, Romani SA, Souza WV, Coutinho AD. Factors involved in Schistosoma mansoni infection, in rural area of northeast Brazil. Mem Inst Oswaldo Cruz. 1997;92:707–715. doi: 10.1590/s0074-02761997000500027. [DOI] [PubMed] [Google Scholar]
  • 15.Carvalho CM, Carvalho OA. Neuroschistosomiasis due to Schistosoma mansoni: a review of pathogenesis, clinical syndromes and diagnostic approaches. Rev Inst Med Trop. 2005;47:179–184. doi: 10.1590/s0036-46652005000400001. [DOI] [PubMed] [Google Scholar]
  • 16.Lee Y-K, Choi T-Y, Jin SY, Lee DW. Imported CNS schistosomiasis: a case report. J Korean Med Sci. 1995;10:57–61. doi: 10.3346/jkms.1995.10.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Pittella JE. The relation between involvement of the central nervous system in schistosomiasis mansoni and the clinical forms of the parasitosis. A review. J Trop Med Hyg. 1991;94:15–21. [PubMed] [Google Scholar]
  • 18.Preidler KW, Riepl T, Szolar D, Ranner G. Cerebral schistosomiasis: MR and CT appearance. AJNR Am J Neuroradiol. 1996;17:1598–1600. [PMC free article] [PubMed] [Google Scholar]
  • 19.Faria AV, Cerqueira EM, Reis F, Pirani C, Damasceno BP, Menezes Neto JR, Zanardi VA. Apresentações da esquistossomose no sistema nervoso central: correlação clínica e radiológica. Radiol Bras. 2002;35:47–50. [Google Scholar]
  • 20.Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Micahlak A, Spahr L, Huet PM, Pomier-Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology. 1999;117:640–644. doi: 10.1016/s0016-5085(99)70457-9. [DOI] [PubMed] [Google Scholar]
  • 21.Thuluvath PJ, Edwin D, Yue NC, de Villiers C, Hochman S, Klein A. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology. 1995;21:440–442. [PubMed] [Google Scholar]
  • 22.Ihara H. High signal intensity of globus pallidus on T1-weighted MRI in liver cirrhosis patients: clinical and pathological study. Nippon Igaku Hoshasen Gakkai Zasshi. 1998;58:479–488. [PubMed] [Google Scholar]
  • 23.Maeda H, Sato M, Yoshikawa A, Kimura M, Sonomura T, Terada M, Kishi K. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology. 1997;39:546–550. doi: 10.1007/s002340050464. [DOI] [PubMed] [Google Scholar]
  • 24.Rovira A, Córdoba J, Sanpedro F, Grivé E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology. 2002;59:335–341. doi: 10.1212/wnl.59.3.335. [DOI] [PubMed] [Google Scholar]
  • 25.Awada A, Sullivan S, Palkar V, Sbeih F, Naufal R, Al Rajeh S. Brain magnetic resonance imaging in non-alcoholic cirrhosis. Eur J Radiol. 1995;21:84–88. doi: 10.1016/0720-048x(95)00694-l. [DOI] [PubMed] [Google Scholar]
  • 26.Klos KJ, Ahlskog JE, Josephs KA, Fealey RD, Cowl CT, Kumar N. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging. Probable manganese neurotoxicity. Arch Neurol. 2005;62:1385–1390. doi: 10.1001/archneur.62.9.1385. [DOI] [PubMed] [Google Scholar]
  • 27.Inoue E, Hori S, Narumi Y, Fujita M, Kuriyama K, Kadota T, Kuroda C. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology. 1991;179:551–555. doi: 10.1148/radiology.179.2.2014310. [DOI] [PubMed] [Google Scholar]
  • 28.Genovese E, Maghnie M, Maggiore G, Tinelli C, Lizzoli F, Giacomo C, Pozza S, Campani R. MR imaging of CNS involvement in children affected by chronic liver disease. AJNR Am J Neuroradiol. 2000;21:845–851. [PMC free article] [PubMed] [Google Scholar]
  • 29.Minguez B, Garcia-Pagan JC, Bosch J, Turnes J, Alonso J, Rovira A, Cordoba J. Noncirrotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology. 2006;43:707–714. doi: 10.1002/hep.21126. [DOI] [PubMed] [Google Scholar]
  • 30.Dobson AW, Erikson KM, Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci. 2004;1012:115–128. doi: 10.1196/annals.1306.009. [DOI] [PubMed] [Google Scholar]
  • 31.Yota K, Fell J, Long S, Bynevelt M, Taylor W, Milla P. Long term outcome of brain manganese deposition in patients on home parenteral nutrition. Arch Dis Child. 1998;79:263–265. doi: 10.1136/adc.79.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Machado MA, Jr, Sobrinho FPG, Barbosa VA, Bina JC, Matos HS. Understanding the hyperintensity of the basal ganglia on T1-weighted imaging in patients with schistosomiasis mansoni with portal-systemic encephalopathy. Int J Neuroradiol. 1999;5:261–265. [Google Scholar]
  • 33.Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis. A distinct subset of acquired hepatocerebral degeneration. Arch Neurol. 2003;60:521–528. doi: 10.1001/archneur.60.4.521. [DOI] [PubMed] [Google Scholar]
  • 34.Hazell AS, Butterworth RF. Hepatic encephalopathy: an update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999;222:99–112. doi: 10.1046/j.1525-1373.1999.d01-120.x. [DOI] [PubMed] [Google Scholar]
  • 35.Warren KS. Pathophysiology and pathogenesis of hepatosplenic schistosomiasis mansoni. Bull N Y Acad Med. 1968;44:280–294. [PMC free article] [PubMed] [Google Scholar]
  • 36.Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol. 2005;26:347–351. [PMC free article] [PubMed] [Google Scholar]
  • 37.Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, Mayer J, Lauchart W, Gregor M, Voigt K. MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology. 2000;216:683–691. doi: 10.1148/radiology.216.3.r00se27683. [DOI] [PubMed] [Google Scholar]
  • 38.Sarazin M, Caumes E, Cohen A, Amarenco P. Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation. J Neurol Neurosurg Psychiatry. 2004;75:305–307. [PMC free article] [PubMed] [Google Scholar]
  • 39.Barbosa MM, Lamounier JA, Oliveira EC, Souza MV, Marques DS, Lambertucci JR. Short report: endomyocardial fibrosis and cardiomyopathy in an area endemic for schistosomiasis. Am J Trop Med Hyg. 1998;58:26–27. doi: 10.4269/ajtmh.1998.58.26. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES